scholarly journals 87 Comparison of functional ability in siblings with duchenne muscular dystrophy

Author(s):  
Catherine Rye ◽  
Marion Main ◽  
Francesco Muntoni
2022 ◽  
Author(s):  
Aram Kim ◽  
Mina Park ◽  
Hyung-Ik Shin

Abstract Background: Assessment of pain is not routine, standardized, or well-understood in individuals with Duchenne muscular dystrophy (DMD), even though pain is a common problem reported by more than half of DMD patients. Previous studies in this area included multiple neuromuscular diseases with highly variable phenotypes. Therefore, our aim was to focus on DMD specifically and evaluate comprehensive pain characteristics according to the disease stages, from ambulatory to late non-ambulatory. Methods: This was a cross-sectional study conducted in an out-patient pediatric rehabilitation clinic. Participants were 148 males with confirmed DMD, 14.5±5.3 years of age. Face-to-face interviews were conducted using a structured questionnaire regarding pain frequency, duration, intensity, location, aggravating/relieving factors, pain interference (Brief Pain Inventory), pain quality (PainDETECT Questionnaire), and functional ability (DMD Functional Ability Self-Assessment Tool). Pain characteristics were analyzed according to the clinical stage: ambulatory (Amb), early non-ambulatory (ENA), and late non-ambulatory (LNA).Results: Of the 148 participants who completed the assessment, 66 (44.6%) reported pain during the previous 4 weeks. There were no differences in the pain duration or intensity among the three groups. Pain location (Amb: calf, ENA: knee, LNA: lumbosacral region), aggravating factor (Amb: ambulation, ENA: transfer, LNA: sitting), and relieving factor (Amb: rest and massage, ENA and LNA: positional change) differed according to the clinical stage. Individuals in the LNA stage reported an increase in the frequency of pain and number of pain sites. The effect of pain on mood was also found to be greater in the LNA group than in the other clinical stages. Conclusion: Pain characteristics including location, aggravating/relieving factors, pain frequency, and pain interference change as the disease progresses in patients with DMD. Clinicians could more efficiently and critically assess and manage the patients’ pain aspect, based on these findings.


PEDIATRICS ◽  
1985 ◽  
Vol 75 (6) ◽  
pp. 1168-1169
Author(s):  
RICHARD T. MOXLEY

Abnormal calcium accumulation in skeletal muscle due to altered sarcolemmal integrity may be important in the pathogenesis of Duchenne muscular dystrophy. To evaluate the potential beneficial effect of a calcium channel-blocking agent on the course of Duchenne muscular dystrophy, 105 patients were randomly selected for a double-blind 18-month study utilizing treatment with nifedipine (n = 54) or placebo (n = 51). Muscle strength, contractures, functional ability, cardiopulmonary changes, and laboratory data were monithred; the detailed results are published elsewhere.


2010 ◽  
Vol 42 ◽  
pp. 815-816
Author(s):  
Jasjit K. Deol ◽  
Ilona Schmalfuss ◽  
Donovan J. Lott ◽  
Sean A. Germain ◽  
Sunita Mathur ◽  
...  

2005 ◽  
Vol 9 (6) ◽  
pp. 387-393 ◽  
Author(s):  
Ernesto A.C. Beenakker ◽  
Natalia M. Maurits ◽  
Johanna M. Fock ◽  
Oebele F. Brouwer ◽  
Johannes H. van der Hoeven

2011 ◽  
Vol 43 (Suppl 1) ◽  
pp. 270-271
Author(s):  
Donovan J. Lott ◽  
Rachel Clark ◽  
Sean Forbes ◽  
Claudia Senesac ◽  
Glenn Walter ◽  
...  

Author(s):  
B El-Aloul ◽  
Y Wei ◽  
K Speechley ◽  
C Campbell

Background: Fatigue is frequent and disabling in adults with neuromuscular disorders, but not well characterized in paediatric neuromuscular disorders. Recently, fatigue was reported to be associated with poor health-related quality of life in children with Duchenne muscular dystrophy (DMD). Determinants of fatigue—a modifiable symptom—have not been studied in DMD. Our objective was to explore risk factors for fatigue in children with DMD. Methods: Patients aged 4–17 years identified via the Canadian Neuromuscular Disease Registry received mailed questionnaires. Fatigue was assessed using the PedsQLTM Multidimensional Fatigue Scale (patient- and parent-report). Standardized measures for depressive symptoms, sleep disturbances, functional ability and physical activity were used. Spearman’s correlations and Wilcoxon rank-sum tests were computed. Results: Of 194 eligible patients, 64 have responded to date. DMD patients reported greater fatigue than healthy controls from published data. Depressive symptoms were associated with greater fatigue, by patient-report (ρ=-0.44, P<0.001) and parent-report (ρ=-0.40, P=0.002). Sleep disturbances were associated with greater fatigue, by patient-report (ρ=-0.41, P=0.007) and parent-report (ρ=-0.51, P<0.001). Greater functional ability was associated with less fatigue, by parent-report (ρ=0.30, P=0.02). Physical activity and ambulatory status were not associated with fatigue. Conclusions: Fatigue is a significant issue in DMD. Depressive symptoms and sleep disturbances are associated with fatigue, warranting attention in therapeutic strategies to reduce fatigue.


2015 ◽  
Vol 25 (12) ◽  
pp. 937-944 ◽  
Author(s):  
Erik Landfeldt ◽  
Anna Mayhew ◽  
Michelle Eagle ◽  
Peter Lindgren ◽  
Christopher F. Bell ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document